-

SHAREHOLDER ALERT: Robbins LLP Announces that Yalla Group Limited (YALA) is Being Sued for Misleading Shareholders

SAN DIEGO--(BUSINESS WIRE)--Shareholder rights law firm Robbins LLP announces that a class action was filed on behalf of all persons and entities that purchased or otherwise acquired Yalla Group Limited (NYSE: YALA) American Depository Shares (ADSs) between September 30, 2020 and August 8, 2021, for violations of the Securities Exchange Act of 1934. Yalla is a voice-centric social networking and entertainment platform that operates mainly in the Middle East and Northern Aftica region.

If you suffered a loss due to Yalla Group Limited's misconduct, click here.

Yalla Group Limited (YALA) Overstated its User Metrics and Revenue

According to the complaint, Yalla held its U.S. initial public offering ("IPO") on September 29, 2020. The Registration Statement in support of the IPO touted the Company’s financial performance and revenue growth. However, during the relevant period, defendants failed to disclose that Yalla overstated its user metrics and revenue. On May 19, 2021, Swan Street Research issued a report entitled "Is Yalla Group a Multi $B Fraud? The 'Clubhouse of the Middle East' UAE Tech Unicorn that Never Was." The report alleged that Yalla had been inflating its financial metrics, including its user data and its revenue, and characterized Yalla's financial statements as "not credible." On this news, the price of Yalla ADSs fell $1.31, or 7.15%, to close at $17.01 per ADS on May 19, 2021.

On May 20, 2021, The Bear Cave issued a report entitled "Problems at Yalla Group" and Gotham City Research tweeted it was shorting Yalla ADSs. On this news, Yalla's shares fell an additional 6%, to close at $15.96 on May 20, 2021.

On August 9, 2021, Yalla issued a press release disclosing its unaudited second quarter 2021 financial results, announcing quarterly revenue of $66.62 million, which missed analysts' expectations. On this news, the price of Yalla's ADSs fell nearly 18.9%, to close at 10.99 on August 10, 2021.

If you purchased shares of Yalla Group Limited (YALA) between December 28, 2016 and August 3, 2021, you have until October 12, 2021, to ask the court to appoint you lead plaintiff for the class.

All representation is on a contingency fee basis. Shareholders pay no fees or expenses.

Contact us to learn more:
Lauren Levi
(800) 350-6003
llevi@robbinsllp.com
Shareholder Information Form

Robbins LLP is a nationally recognized leader in shareholder rights law. To be notified if a class action against YALA Group Limited settles or to receive free alerts when corporate executives engage in wrongdoing, sign up for Stock Watch today.

Attorney Advertising. Past results do not guarantee a similar outcome.

Contacts

Lauren Levi
Robbins LLP
5040 Shoreham Place
San Diego, CA 92122
llevi@robbinsllp.com
(800) 350-6003
www.robbinsllp.com

Industry:

Robbins LLP

NYSE:YALA
Release Versions
English

Contacts

Lauren Levi
Robbins LLP
5040 Shoreham Place
San Diego, CA 92122
llevi@robbinsllp.com
(800) 350-6003
www.robbinsllp.com

More News From Robbins LLP

CPNG Class Action Alert: Robbins LLP Reminds Investors with Losses in Coupang, Inc. to Contact the Firm for Information About Leading the Class Action

SAN DIEGO--(BUSINESS WIRE)--Robbins LLP reminds stockholders that a class action was filed on behalf of all investors who purchased or otherwise acquired Coupang, Inc. (NYSE: CPNG) securities between April 6, 2025 and December 16, 2025. Coupang describes itself as one of the fastest-growing technology and commerce companies in the world, providing retail, restaurant delivery, video streaming, and fintech services to customers around the world under brands that include Coupang, Coupang Eats, Cou...

Vistagen Therapeutics, Inc. Stockholders with Large Losses in VTGN Should Contact Robbins LLP for Information About Leading the Vistagen Therapeutics, Inc. Securities Class Action Lawsuit

SAN DIEGO--(BUSINESS WIRE)--Robbins LLP reminds investors that a class action was filed on behalf of all investors who purchased or otherwise acquired Vistagen Therapeutics, Inc. (NASDAQ: VTGN) common stock between April 1, 2024 and December 16, 2025. Vistagen Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the development and commercialization of therapies for neuropsychiatric and neurological disorders. For more information, submit a form, email attorney Aaron Dumas...

Investor Notice: Shareholder Rights Law Firm Robbins LLP Informs Investors of the Beyond Meat, Inc. Securities Class Action Lawsuit

SAN DIEGO--(BUSINESS WIRE)--Robbins LLP informs stockholders that a class action was filed on behalf of all investors who purchased or otherwise acquired Beyond Meat, Inc. (NASDAQ: BYND) securities between February 27, 2025 and November 11, 2025. Beyond Meat operates in the food industry, developing, manufacturing, marketing, and selling plant-based meat products under the "Beyond" brand name in the U.S. and internationally. For more information, submit a form, email attorney Aaron Dumas, Jr.,...
Back to Newsroom